Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia.

Reid MA, Kraguljac NV, Avsar KB, White DM, den Hollander JA, Lahti AC.

Schizophr Res. 2013 Jul;147(2-3):348-54. doi: 10.1016/j.schres.2013.04.036. Epub 2013 May 21.

2.

Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging.

Hutcheson NL, Reid MA, White DM, Kraguljac NV, Avsar KB, Bolding MS, Knowlton RC, den Hollander JA, Lahti AC.

Schizophr Res. 2012 Sep;140(1-3):136-42. doi: 10.1016/j.schres.2012.06.039. Epub 2012 Jul 23.

3.

Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.

Bustillo JR, Jones T, Chen H, Lemke N, Abbott C, Qualls C, Stromberg S, Canive J, Gasparovic C.

Schizophr Bull. 2017 May 1;43(3):611-619. doi: 10.1093/schbul/sbw122.

PMID:
27550776
4.

Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia.

Reid MA, Stoeckel LE, White DM, Avsar KB, Bolding MS, Akella NS, Knowlton RC, den Hollander JA, Lahti AC.

Biol Psychiatry. 2010 Oct 1;68(7):625-33. doi: 10.1016/j.biopsych.2010.04.013. Epub 2010 Jun 8.

5.

Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia.

Kraguljac NV, White DM, Reid MA, Lahti AC.

JAMA Psychiatry. 2013 Dec;70(12):1294-302. doi: 10.1001/jamapsychiatry.2013.2437.

PMID:
24108440
6.

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.

J Psychiatr Res. 2007 Oct;41(8):625-34. Epub 2006 Sep 1.

PMID:
16949099
7.

Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).

Tayoshi S, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numata S, Iga J, Nakataki M, Ueno S, Harada M, Ohmori T.

Schizophr Res. 2009 Mar;108(1-3):69-77. doi: 10.1016/j.schres.2008.11.014. Epub 2008 Dec 20.

PMID:
19097753
8.

Dopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in vivo magnetic resonance spectroscopic imaging.

Gröger A, Kolb R, Schäfer R, Klose U.

PLoS One. 2014 Jan 8;9(1):e84081. doi: 10.1371/journal.pone.0084081. eCollection 2014.

9.

Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.

Coughlin JM, Tanaka T, Marsman A, Wang H, Bonekamp S, Kim PK, Higgs C, Varvaris M, Edden RA, Pomper M, Schretlen D, Barker PB, Sawa A.

Curr Mol Med. 2015;15(2):176-83.

10.

Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.

Tandon N, Bolo NR, Sanghavi K, Mathew IT, Francis AN, Stanley JA, Keshavan MS.

Schizophr Res. 2013 Aug;148(1-3):59-66. doi: 10.1016/j.schres.2013.05.024. Epub 2013 Jun 20.

PMID:
23791389
11.

Proton magnetic resonance spectroscopy of the human brain in schizophrenia.

Deicken RF, Johnson C, Pegues M.

Rev Neurosci. 2000;11(2-3):147-58. Review.

PMID:
10718151
12.

Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.

Yoo SY, Yeon S, Choi CH, Kang DH, Lee JM, Shin NY, Jung WH, Choi JS, Jang DP, Kwon JS.

Schizophr Res. 2009 Jun;111(1-3):86-93. doi: 10.1016/j.schres.2009.03.036. Epub 2009 Apr 29.

PMID:
19406622
13.

Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate.

Fayed N, Garcia-Campayo J, Magallón R, Andrés-Bergareche H, Luciano JV, Andres E, Beltrán J.

Arthritis Res Ther. 2010;12(4):R134. doi: 10.1186/ar3072. Epub 2010 Jul 7.

14.

Single voxel proton magnetic resonance spectroscopy in post-stroke depression.

Glodzik-Sobanska L, Slowik A, McHugh P, Sobiecka B, Kozub J, Rich KE, Urbanik A, Szczudlik A.

Psychiatry Res. 2006 Dec 1;148(2-3):111-20. Epub 2006 Nov 7.

PMID:
17088051
15.

Myoinositol and glutamate complex neurometabolite abnormality after mild traumatic brain injury.

Kierans AS, Kirov II, Gonen O, Haemer G, Nisenbaum E, Babb JS, Grossman RI, Lui YW.

Neurology. 2014 Feb 11;82(6):521-8. doi: 10.1212/WNL.0000000000000105. Epub 2014 Jan 8.

16.

A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.

Reid MA, White DM, Kraguljac NV, Lahti AC.

Schizophr Res. 2016 Feb;170(2-3):341-50. doi: 10.1016/j.schres.2015.12.003. Epub 2015 Dec 21.

PMID:
26718333
17.

Higher glutamate+glutamine and reduction of N-acetylaspartate in posterior cingulate according to age range in patients with cognitive impairment and/or pain.

Fayed N, Andrés E, Viguera L, Modrego PJ, Garcia-Campayo J.

Acad Radiol. 2014 Sep;21(9):1211-7. doi: 10.1016/j.acra.2014.04.009. Epub 2014 Jun 26.

PMID:
24981958
18.

Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease.

Gröger A, Chadzynski G, Godau J, Berg D, Klose U.

Eur Radiol. 2011 Sep;21(9):1962-9. doi: 10.1007/s00330-011-2123-5. Epub 2011 Apr 12.

PMID:
21484351
19.

Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies.

Kegeles LS, Shungu DC, Anjilvel S, Chan S, Ellis SP, Xanthopoulos E, Malaspina D, Gorman JM, Mann JJ, Laruelle M, Kaufmann CA.

Psychiatry Res. 2000 May 15;98(3):163-75.

PMID:
10821999
20.

Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.

Natsubori T, Inoue H, Abe O, Takano Y, Iwashiro N, Aoki Y, Koike S, Yahata N, Katsura M, Gonoi W, Sasaki H, Takao H, Kasai K, Yamasue H.

Schizophr Bull. 2014 Sep;40(5):1128-39. doi: 10.1093/schbul/sbt124. Epub 2013 Sep 10.

Supplemental Content

Support Center